High tumor mutational burden predicts survival and responses to ICI immunotherapy in a cancer-dependent manner https://www.medrxiv.org/content/10.1101/2023.08.29.23294599
High tumor mutational burden predicts survival and responses to ICI immunotherapy in a cancer-dependent manner https://www.medrxiv.org/content/10.1101/2023.08.29.23294599